Skip to content
GLP-1 Decoder

Semaglutide Vision: How Common, How Long It Lasts

The semaglutide labels name retinopathy as a reported side effect but give no trial rate for it.

In the label
Listed, no rate given
Label term
retinopathy

A quick look at Wegovy

How long it remains in the body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d half is gone, and after five half-lives (35 d) about 3% remains.

Weight loss in its main trial
Wegovy (STEP 1)14.9%Placebo2.4%

Over 68 weeks, STEP 1 reported 14.9% of body weight, compared with 2.4% on placebo.

Prices over time
202520262027$1,349.02$0List priceSelf-pay

The maker's price page provides monthly list prices and self-pay offers in US dollars.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

An alternative listed in the Ozempic label

The Ozempic label gives no rate for vision changes. It lists five side effects most often, with rates for each.

Table 1. Adverse Reactions listed for Placebo-Controlled Trials Reported in ≥5% of OZEMPIC-Treated Patients with Type 2 Diabetes Mellitus
Side effectPlaceboOzempic 0.5 mgOzempic 1 mgMore than placebo, 1 mg
Nausea6.1%15.8%20.3%+14.2 points
Vomiting2.3%5%9.2%+6.9 points
Diarrhea1.9%8.5%8.8%+6.9 points
Abdominal pain4.6%7.3%5.7%+1.1 points
Constipation1.5%5%3.1%+1.6 points

Source: Ozempic label (DailyMed).

From the FDA DailyMed label.

What the label says

Below is the label's exact wording for vision changes:

“with type 2 diabetes and high cardiovascular risk, more events of diabetic retinopathy complications occurred in patients treated with OZEMPIC (3.0%) compared to placebo (1.8%).”

From the FDA DailyMed label.